Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 5—May 2017
Research Letter

Management of Bartonella Prosthetic Valve Endocarditis without Cardiac Surgery

Padmasayee PapineniComments to Author , Aisling Carroll, Johannes Radvan, Carolyn Hemsley, John Chambers, Nicholas Cortes, Timothy Harrison, John L. Klein, and Papineni
Author affiliations: St. Thomas' Hospital, London, UK (P. Papineni, C. Hemsley, J. Chambers, J.L. Klein); University Hospital Southampton, Southampton, UK (A. Carroll); Royal Bournemouth Hospital, Bournemouth, UK (J. Radvan); Basingstoke and North Hampshire Hospital,
Basingstoke, UK (N. Cortes); Public Health England, London (T. Harrison)

Main Article

Table

Bartonella antibody titers in cases 1 and 2 by month after diagnosis*

Month after diagnosis
 B. henselae IgM
 B. henselae IgG
 B. quintana IgM
 B. quintana IgG
Case 1
0 40 32,768 <20 1,024
8 <20 16,385 <20 512
11 20 8,096 <20 512
16 <20 8,096 <20 256
25 <20 4,096 <20 64
43
 <20
 2,048
 <20
 64
Case 2
0 <20 8,192 <20 512
16 <20 ≥512 <20 64
41 <20 64 <20 <64

*All time points were assayed in parallel. Antibody titers are the inverse of the greatest dilution that exhibited a reaction.

Main Article

Page created: April 14, 2017
Page updated: April 14, 2017
Page reviewed: April 14, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external